Indications & Dose:
Schizophrenia
BY MOUTH
Adult: Initially 37 mg once daily, increased if necessary up to 148 mg once daily
Schizophrenia when given with concomitant moderate CYP3A4 inhibitors (e.g. diltiazem, erythromycin,mfluconazole, and verapamil)
BY MOUTH
Adult: Initially 18.5 mg once daily (max. per dose 74 mg once daily)
Contraindications:
Side Effects:
Common or very commonAnxiety .musculoskeletal stiffness UncommonCatatonia .decreased appetite . dysarthria .dysuria .hotflush . myalgia
.nightmares Frequency not known Angina .AV block .bradycardia .dysphagia .panic attacks . pruritus .suicidalbehaviour. vertigo
Cautions:
High doses in elderly .susceptibility to QTinterval prolongation
Precautions:
Interaction:
Warnings:
Adverse Effects:
Lactations:
PREGNANCY Use only if potential benefit outweighs risk—limited information available.
HEPATIC IMPAIRMENT Initially 18.5mg once daily, up to max. 74mg once daily in moderate impairment. Use with caution in severe
impairment—initially 18.5mg once daily, up to max. 37mg once daily.
RENAL IMPAIRMENT Initially 18.5mg once daily, up to max. 74mg once daily if eGFR less than 50 mL/minute/1.73m2. Manufacturer advises
use only if potential benefit outweighs risk if eGFR less than 15 mL/minute/1.73m2.
Special Precautions:
Counselling:
Side Effects Or Adverse Reactions:
Patient And Carer Advice:
© Pakistan Drug Directory. All Rights Reserved.
Designed By: Pakistan Drug Directory Team